Tag: cancer immunotherapy May 20, 2024 DiPersio receives innovation awardOncologist recognized for developing new therapies for blood cancers.National Leaders May 10, 2024 $5 million grant supports innovative immunotherapies against blood cancersLeukemia & Lymphoma Society supports trials in cell-based immunotherapies, cancer vaccines.News Release March 28, 2024 Some sarcoma patients improve with T cell immunotherapyStrategy effective against some rare, aggressive sarcomas with no other treatment options.News Release December 5, 2023 Schreiber receives scientific innovator awardImmunobiologist honored for contributions to the field of cancer immunology.News Release April 17, 2023 Investigational drug may improve stem cell transplantation for multiple myeloma patientsIf approved, drug could change standard care.News Release March 31, 2023 Jumping genes in cancer cells open door to new immunotherapiesAnalysis of 33 tumor types identifies new immunotherapy targets.News Release February 16, 2023 Cancer patients who don’t respond to immunotherapy lack crucial immune cellsBoosting such cells may help more patients benefit from immunotherapy.News Release November 22, 2022 Drug triggers immune cells to attack prostate cancerCompound kills tumors in mice, human cancer cells in multiple ways.News Release September 15, 2022 Schreiber honored for cancer immunotherapy researchImmunologist recognized as pioneer in the field.National Leaders August 23, 2022 Puram honored for research on head and neck cancerDoris Duke Charitable Foundation recognizes work on cancer immunotherapy.National Leaders June 29, 2021 Cell-based immunotherapy shows promise against melanomaEffective against blood cancers, natural killer cells also may be effective against solid tumors.News Release February 11, 2021 Aggressive brain tumor mapped in genetic, molecular detailGlioblastoma study could lead to new treatments, including better immunotherapies.News Release Posts navigation 1 2 Next ›
